PMID int64 27.8M 36.2M | Title/Abstract stringlengths 7 10.7k | MeshTerms stringlengths 7 104 | SemanticTypes stringlengths 4 84 |
|---|---|---|---|
34,674,010 | gmaoc modul seed germin regul ja biosynthesi soybean allen oxid cyclas gmaoc determin gwas rt pcr signific associ seed germin soybean regul seed germin promot ja accumul seed germin phase critic compon plant lifecycl better understand mechan behind seed germin soybean need use genom wide associ studi gwas detect gwas signal chromosom gwas signal snp locat within untransl region glymag encod allen oxid cyclas name gmaoc analysi real time pcr demonstr express level gmaoc low germin varieti kf carri snp higher high germin varieti nn carri snp c two varieti kf show higher ja concentr nn h imbibit moreov overexpress gmaoc led increas concentr jasmon acid ja soybean hairi root arabidopsi thaliana furthermor found gmaoc oe line show less seed germin wild type wt normal condit arabidopsi day aba treatment transgen line exhibit lower seed germin higher express level atabi compar wt indic overexpress gmaoc result hypersensit aba find demonstr gmaoc promot ja accumul help regul seed germin soybean | D029681;D018525 | T116;T038 |
34,674,009 | identif character qtl spike morpholog trait plant height head date deriv genom natur resynthet allohexaploid wheat qhdcau head date delimit physic interv approxim mb harbor three constan like zinc finger gene spike morpholog trait plant height head date play import role yield improv wheat reveal genet factor control spike morpholog trait plant height head date genom conduct analysi quantit trait locus qtl use f recombin inbr line ril deriv cross common wheat taa resynthes allohexaploid wheat xx similar aabb genom total environment stabl qtl sub genom spike length sl fertil spikelet number per spike fsn steril spikelet number per spike ssn total spikelet number per spike tsn spike compact sc plant height pht head date hd detect among eight appear novel qtl furthermor qhdcau qphtcau share ident confid interv delimit physic interv approxim mb annot gene includ three constan like zinc finger gene traescsdg traescsdg traescsdg studi help elucid molecular mechan seven trait sl fsn ssn tsn sc pht hd provid potenti valuabl resourc genet improv | D040641;D014908 | T168;T002;T028 |
34,674,006 | interv time midfront delta oscil impair parkinson diseas patient freez gait gait abnorm cognit dysfunct common patient parkinson diseas pd get wors diseas progress recent evid suggest strong relationship gait abnorm cognit dysfunct pd patient impair cognit control could one caus abnorm gait pattern howev pathophysiolog mechan cognit dysfunct pd patient gait problem unclear collect scalp electroencephalographi eeg signal interv time task investig cortic mechan cognit dysfunct pd patient pdfog n without pdfog n freez gait well control subject n result show pdfog group exhibit lowest maximum respons densiti around compar pdfog control group respons densiti peak correl gait abnorm measur fog score eeg data demonstr pdfog decreas midfront delta band power onset target cue also correl maximum respons densiti fog score addit classifi perform better discrimin pdfog pdfog control area curv midfront delta power chosen featur find suggest abnorm midfront activ pdfog relat cognit dysfunct describ mechanist relationship cognit gait function pdfog overal result could advanc develop novel biosignatur brain stimul approach pdfog | D060825;D020233;D010300 | T033;T048;T047;T184 |
34,674,005 | acut post acut neurolog manifest covid present find critic apprais futur direct acut post acut neurolog symptom sign diagnos document increas number patient infect sever acut respiratori syndrom coronavirus sar cov caus coronavirus diseas covid review aim summar current literatur address neurolog event follow sar cov infect discuss limit exist literatur suggest futur direct would strengthen understand neurolog sequela covid presenc neurolog manifest symptom sign diagnos onset sar cov infect associ sever diseas demonstr longer hospit stay higher hospit death rate continu presenc sequela discharg although biolog mechan postul find evid base data still lack clear defin incid rang characterist outcom manifest particular non hospit patient addit data low middl incom countri scarc lead uncertainti measur neurolog find covid refer geographi ethnic socio cultur set health care arrang consequ present specif phenotyp would specifi post covid long covid neurolog syndrom yet identifi | D000086382;D009422 | T047;T067 |
34,674,004 | cerebr derail myocardi infarct mechan effect signal ischem heart brain myocardi infarct mi lead caus death among ischem heart diseas associ sever long term cardiovascular complic angina infarct arrhythmia heart failur howev mi frequent accompani non cardiovascular multipl comorbid includ brain disord stroke anxieti depress cognit impair accumul experiment clinic evid suggest causal relationship mi stroke precis under mechan yet elucid inde risk stroke remain current challeng patient mi spite improv medic treatment among patient popul reduc risk stroke review effect signal ischem heart brain neuroinflamm neuron apoptosi neurogenesi possibl actor mediat effect system inflamm immunorespons extracellular vesicl microrna discuss | D001921;D009203;D009206 | T047;T023;T024 |
34,674,002 | gastroschisi success prospect evalu treatment model middl incom countri research adopt care protocol high incom countri level iiiii hospit middl incom countri decreas morbid mortal associ gastroschisi | D020139 | T047 |
34,674,001 | delay stenosi regress drug coat balloon angioplasti femoropoplit arteri lesion paclitaxel potenti induc lumen enlarg vessel enlarg heal dissect plaqu regress studi carri determin possibl relev factor delay stenosi regress drug coat balloon dcb angioplasti femoropoplit fp arteri lesion total de novo fp lesion final dcb angioplasti institut may june among case residu stenosi detect duplex ultrasonographi dus procedur includ studi signific stenosi defin peak systol veloc ratio dus follow dus routin perform month procedur defin case without stenosi case delay stenosi regress accord follow dus dus show lesion residu stenosi dcb angioplasti delay stenosi regress observ lesion month procedur percentag lesion contain calcifi plaqu detect intravascular ultrasound analysi signific higher non regress group regress group vs p vessel remodel dissect pattern associ delay stenosi regress result analys indic delay stenosi regress may occur dcb angioplasti fp lesion half case residu stenosi delay stenosi regress may difficult case calcifi lesion | D000800;D058729;D058226 | T047;T046;T061;T020;T031 |
34,673,999 | reduc concentr femor nerv block effect periop pain control follow acl reconstruct retrospect review femor nerv block fnb routin use region analges techniqu anterior cruciat ligament acl reconstruct one method balanc analges effect function impair fnbs may control concentr local anesthet util block | D005267;D009407 | T023;T061 |
34,673,998 | hyperosmolar dextros inject osgood schlatter diseas doubl blind random control trial osgood schlatter diseas osd one common caus long term knee pain lead function limit long term deform tubercl interf kneel impair peer import sport particip nonetheless patient manag continu reli usual conserv method studi examin use hyperosmolar dextros inject patient osd | D055034 | T047 |
34,673,997 | outpati urolog europ care patient urolog diseas outpati urolog secur near home treatment specialist urolog locat general practition urolog clinic compar littl known structur field work area urolog survey eau section esuo outpati offic urolog https uroweborgsectionesuo show divers term content organis sector europ outpati urologist thus half profession urologist work full time divers relat diagnost therapeut method outpati urolog work condit outpati urologist comparison inform european countri contrast data german offic urolog one type outpati urolog | D014570;D014572 | T091;T047 |
34,673,996 | fat contain pelvic lesion femal pelvic tumor common femal broad differenti diagnosi clinic manag pelvic tumor vari wide observ surgic resect imag play pivot role diagnosi clinic decis make case particular imag help determin organ origin tissu content tumor import step narrow differenti diagnosi fat characterist appear often easili identifi ultrasonographi us comput tomographi ct magnet reson imag mri amount distribut intralesion fat vari differ type tumor macroscop intralesion fat often easili recogn hyperecho appear us low attenu ct similar subcutan fat mri macroscop fat hyperintens weight tw imag characterist signal loss fat satur sequenc india ink artifact oppos phase tw imag macroscop fat hallmark teratoma common ovarian neoplasm uterin lipoleiomyoma periton loos bodi intraperiton extraperiton primari lipomat tumor lipoma liposarcoma extra adren myelolipoma pelvic mass distinguish presenc macroscop fat howev imag diagnosi pelvic mass contain minim microscop fat immatur ovarian teratoma steroid cell ovarian neoplasm extramedullari hematopoiesi present diagnost challeng owe nonspecif appear us ct obtain mri phase oppos phase dual echo tw sequenc depict chemic shift artifact help distinguish lesion | D010051;D013724 | T191 |
34,673,995 | feasibl mri base radiom model presurg evalu tumor bud local advanc rectal cancer build valid magnet reson imag base radiom model preoper evalu tumor bud tb local advanc rectal cancer larc | D012004 | T191 |
34,673,994 | serum immunoglobulin g limit diagnost valu immunoglobulin g relat chronic rhinosinus investig profil factor influenc serum igg level evalu diagnost valu serum igg igg relat crs | D012220;D012852 | T047 |
34,673,992 | rapid identif resist urinari tract pathogen bacteria use deep learn base spectroscop analysi resist urinari tract pathogen bacteria various antibiot increas requir rapid detect infecti pathogen accur time antibiot treatment propos rapid diagnosi strategi antibiot resist bacteria urinari tract infect uti base surfac enhanc raman scatter ser use posit charg gold nanoparticl planar solid ser substrat intellig identif model ser spectra base deep learn techniqu construct realiz rapid ultrasensit non label detect pathogen bacteria total ser spectra collect isol belong speci common uti bacteria work realiz identif bacteri speci antibiot sensit multidrug resist mdr via convolut neural network cnn method signific simplifi raman data process process without background remov smooth howev achiev classif accuraci signific greater accuraci tradit multivari statist analysi algorithm princip compon analysi combin k nearest neighbor pca knn work clear elucid potenti combin ser deep learn techniqu realiz cultur free identif pathogen bacteria associ antibiot sensit | D000077321;D024881 | T032;T066 |
34,673,991 | evalu two modal periop treatment manag extrem truncal soft tissu sarcoma neoadjuv concurr chemoradiotherapi sequenti treatment patient local advanc grade extremitytrunc soft tissu sarcoma sts high risk recurr object studi assess efficaci feasibl neoadjuv concurr chemoradiotherapi ccrt select grade patient limb trunk wall sts compar schedul sequenti approach combin neoadjuv chemotherapi adjuv radiotherapi | D020360;D012509 | T191;T061 |
34,673,990 | surviv outcom hematolog complic growth impair sequenti chemoradiotherapi intracrani nggcts retrospect studi studi aim evalu clinic featur prognost factor surviv outcom patient intracrani nongerminomat germ cell tumor nggcts particular focus treatment toxic long term survivor | D009373;D013921 | T191;T047 |
34,673,989 | contrast attent bias saccad choic task gain insight human observ select item visual field pit two attent bias one anoth singl free choic design first bias nasal tempor asymmetri free choic task observ tend choos target appear tempor hemifield target appear nasal hemifield second choic bias found studi attent prime observ select stimulus share featur preced target stimulus share featur previous distractor strong tendenc choos preced search target bias increas often search repeat result show bias affect saccad choic also show nasal tempor bias modul strength prime effect vice versa prime effect stronger stimuli appear tempor nasal hemifield nasal tempor bias similar prime unprim target addit find first show search repetit lead faster saccad observ differ effect nta prime bias may reflect differ neural mechan thought behind bias bias lower level may outrank higher level bias least effect visual attent | D000070379;D012438 | T033;T041 |
34,673,986 | peripher blood transcript signatur intern mibg therapi relaps refractori neuroblastoma patient identifi earli late biomark intern exposur metaiodobenzylguanidin mibg target radiat therapi develop treatment advanc neuroblastoma previous shown patient cohort use predict absorb dose associ earli exposur h treatment expand studi identifi gene express differ associ mibg exposur day treatment total rna peripher blood lymphocyt isol whole blood sampl repres relaps refractori neuroblastoma patient mibg treatment found sever transcript predict earli exposur return baselin level day howev select transcript return baselin h select pathway specif transcript differenti express transcript cdkna p fdxr p ddb p bbc p show highest regul h mibg exposur mean log fold chang respect day mibg select transcript differenti express xpc statb prkdc mdm polh igfr sgk display signific regul h signific regul day interest transcript fdxr p ddb p bcl p sesn p maintain differenti express day mibg treatment result suggest transcript level dna repair apoptosi ioniz radiat induc cellular stress still chang day mibg treatment studi showcas use biodosimetri gene express panel predict biomark follow earli h late day intern exposur find also demonstr util transcript panel differenti expos non expos individu day exposur intern | D019797 | T130;T121;T109 |
34,673,984 | appear concern uniqu associ lpp amplitud pictur oneself number psychiatr disord includ bodi dysmorph disord bdd anorexia nervosa bulimia nervosa social anxieti disord character heighten appear concern increas cognit perceptu bias toward one physic appear present studi examin individu differ self report appear anxieti symptom bdd relat late posit potenti lpp index stimulus signific respons pictur oneself stranger object among femal colleg student result indic lpp larger pictur oneself compar pictur stranger object yale brown obsess compuls scale modifi bodi dysmorph disord appear anxieti inventori scale relat increas lpp pictur oneself stranger object find suggest lpp elicit pictur oneself may function neural marker appear concern could leverag studi develop mainten rang psychiatr disord character increas appear concern | D000856;D057215 | T048 |
34,673,983 | success rituximab treatment patient anca negat granulomatosi polyang case report year old woman refer hospit evalu fever nasal congest deaf multipl pulmonari nodul refractori antibiot use despit negat find antineutrophil cytoplasm antibodi diagnos granulomatosi polyangi base analysi biopsi specimen pulmonari nodul administr oral prednisolon six intraven cyclophosphamid ivci result prompt relief symptom disappear pulmonari nodul howev month complet ivci therapi nasal congest deaf flare increas c reactiv protein level repeat comput tomographi reveal left lung nodul consequ underw remiss induct mainten therapi rituximab rtx result symptomat improv disappear pulmonari nodul month patient remain remiss thereaft therefor rtx may effect therapeut option even absenc detect autoantibodi | D019268;D014890 | T129;T047;T116 |
34,673,978 | rhus coriaria l new candid control metabol syndrom systemat review rhus coriaria l rc decidu shrub sever pharmacolog activ evid effect rc weight hyperlipidaemia hypertens diabet mellitus present studi book thesi internet base resourc pubm web scienc scopus embas cochran ovid googl scholar search english arab persian literatur decemb keyword rhus coriaria l sumac metabol syndrom medic condit hyperlipidaemia hypertens obes diabet mellitus inclus criteria full text anim human studi conduct rc evalu efficaci compon metabol syndrom met jadad scale use assess qualiti evid | D029045 | T002 |
34,673,976 | inbreed nativ american ancestri child mortal link human select paediatr medicin children relat parent show increas risk earli mortal nativ american genom typic exhibit long stretch homozygos latin american high heterogen regard individu burden homozygos proport type nativ american ancestri analys nationwid mortal genom wide genotyp data admix chilean investig relationship common caus child mortal homozygos nativ american ancestri result two stage linear poisson regress reveal strong associ sum length run homozygos sroh megabas mb genom mortal due intracrani non traumat haemorrhag foetus newborn increas risk death per mb sroh p disord relat short gestat low birth weight p major indigen popul chile aymara quechua north countri mapuch huillich south individu proport aymara quechua ancestri associ increas risk death due anencephali similar malform p risk death due edward patau trisomi syndrom decreas per aymara quechua ancestri proport p per mapuch huillich ancestri proport p present result suggest short gestat low birth weight intracrani non traumat haemorrhag mediat negat effect inbreed human select independ valid identifi associ common caus child death homozygos fine scale ancestri proport may inform paediatr medicin | D046688;D007178 | T040;T081 |
34,673,975 | chemic composit energi content amino acid digest cyperus esculentus co product fed grow pig studi conduct determin chemic composit de ne content appar standard ileal digest aid sid aa cyperus esculentus co product fed grow pig five c esculentus co product includ expel press c esculentus cake epcc cold press c esculentus cake cpcc solvent extract c esculentus meal secm c esculentus distil dri grain solubl ce ddgs c esculentus meal cem exp total crossbr grow pig duroc landrac yorkshir bw kg fed one six diet complet random design diet includ corn soybean meal basal diet five experiment diet contain c esculentus co product exp breed grow pig bw kg surgic fit cannula distal ileum allot one four experiment diet period youden squar design diet includ one n free diet three experiment diet contain c esculentus co product includ epcc secm ce ddgs result indic secm ce ddgs greatest content starch cp respect content cf ndf adf greatest cem lowest secm dm basi de predict ne appar total tract digest attd ge valu c esculentus co product rang kcalkg kcalkg kcalkg respect epcc cpcc greatest de predict ne valu cpcc epcc secm greatest attd ge wherea cem lowest de ne attd ge p ndf adf negat correl de ne p aid sid cp vari respect epcc secm greater sid cp ile met val asp cys tyr compar ce ddgs p result indic chemic composit de ne well aa digest c esculentus co product obtain differ process techniqu vari great base energi content aa digest epcc better feedstuff grow pig compar c esculentus co product | D000596;D029786 | T116;T121;T002;T123 |
34,673,974 | identif antibiot trigger dissemin antibiot resist gene sxtr element use dedic high throughput whole cell biosensor assay mobil genet element mges wide involv dissemin antibiot resist gene integr conjug element sxt even induc specif antibiot sub lethal concentr | D015374;D003227 | T059;T045;T075 |
34,673,973 | microbi adapt evolut bacteri speci adapt signific chang environ mutat follow select phenomenon known adapt evolut develop bioinformat genet engin research adapt evolut progress rapid applic process review summar various mechan bacteri adapt evolut technolog use studi success applic method research industri particular highlight contribut dr l ingram microbi adapt evolut signific impact societi industri applic also evolut emerg control various pathogen | D000222;D001419 | T040;T007 |
34,673,971 | assess genom divers connect riverscap genet hypothes endang rough hornsnail pleurocera foremani follow habitat disrupt southeastern unit state home richest biodivers world last year howev rapid industri urban threaten mani natur area includ freshwat habitat river impound also rapid alter freshwat habitat often result speci extirp extinct coosa river alabama experienc one largest faunal declin modern histori impound make ideal system studi invertebr speci affect reservoir creation one speci rough hornsnail pleurocera foremani endang freshwat snail famili pleurocerida sampl known local p foremani use brad seq measur genet divers assess riverscap genom pattern across current rang p foremani measur gene flow within impound also investig degre p foremani display isol distanc pattern conform broad hypothes put forth popul genet riverin speci like mighti headwat hypothesi predict greater genet divers headwat reach compar mainstem popul like freshwat speci pattern isol distanc observ p foremani also found coosa river dam barrier gene flow genet fragment p foremani like increas howev gene flow appear common within reservoir tributari addit found spatial genet structur p foremani deviat expect mighti headwat hypothesi ad grow bodi research suggest major genet divers low dispers gastropod found mainstem popul | D017753;D005828 | T070;T082;T090 |
34,673,965 | associ treatment intens surviv older patient hodgkin lymphoma hodgkin lymphoma aggress blood cancer high curabl younger patient receiv multiag chemotherapi wors surviv older patient may reflect less aggress treatment compet risk death differ diseas biolog factor | D016896 | T080 |
34,673,964 | assess discord physician famili member regard prognosi patient sever acut brain injuri share decis make requir key stakehold align percept prognosi like treatment outcom | D034462;D011379 | T058;T054;T201 |
34,673,962 | racial ethnic dispar rate covid associ hospit intens care unit admiss hospit death unit state march februari racial ethnic minor group disproportion affect covid | D054624;D017052 | T080 |
34,673,961 | impact genet merit ewe perform effici paramet aim studi investig impact ewe genet merit ewe perform effici paramet studi consist three genet merit group new zealand nz high irish low irish ran inclus genet merit group contain purebr suffolk purebr texel ewe select base matern genet index countri origin name ireland uro star replac index new zealand new zealand matern worth ewe bodi condit score bcs ewe bodi weight bw milk yield milk composit dri matter intak dmi effici paramet analyz use linear mix model ewe bw similar across genet merit group time point p comparison high low irish ewe nz ewe higher bcs mate mid pregnanc lamb week post lamb pl p ewe bw chang similar across genet merit group except mate mid pregnanc ewe bw loss greater nz ewe irish ewe p week pl pl nz ewe gain bw high low irish ewe lost bw p ewe milk yield milk fat total solid gross energi content superior milk produc nz ewe week pl comparison milk produc high irish low irish ewe p nz ewe produc greater quantiti milk solidskg bw week pl compar high irish ewe p low irish ewe greater daili dmi high irish ewe late lactat week pl p greater dmikg ewe bw compar high irish ewe time point p nz ewe wean litter bw equival mate bw low irish ewe wean ewe bw mate p studi present rang paramet across ewe high low genet merit demonstr abil achiev gain select anim high genet merit sheep produc consid genet index tool assist decis make process select replac ewe andor breed ram satisfi anim correct meet breed object system | D007774;D008892 | T031;T042;T168 |
34,673,960 | multiethn whole genom sequenc studi identifi novel loci bone miner densiti present dna sequenc base studi explor genet determin bone miner densiti bmd carri largest whole genom sequenc analysi date femor neck spine bmd n one highest averag sequenc depth implement thus far multiethn sampl caucasian african american louisiana osteoporosi studi los los sampl combin summari statist gefo consortium sever independ sampl various ethnic perform gwas meta analysi n identifi genom risk loci femor neck spine bmd respect find substanti mani previous report suscept loci eg wnt esr reveal sever other either novel wide replic gwas bmd includ two femor neck igf znf one spine sipa although abl uncov ethnic specif differ genet determin bmd identifi sever loci demonstr sex specif associ includ two women pded pign three men trafip nfib lysmd gene base rare variant associ test detect maml regul notch signal pathway previous suggest associ spine bmd find provid novel insight pathophysiolog mechan osteoporosi | D015519;D055106 | T081;T063;T201 |
34,673,959 | genom epidemiolog persist circul mdr shigella sonnei strain associ men sex men msm belgium shigella sonnei resist first line antibiot azithromycin ciprofloxacin rise global aim studi describ epidemiolog mdr sonnei belgium identifi origin circul cluster wgs | D004405;D000072339 | T047;T098 |
34,673,958 | valu bias competit auditori system brain attent captur previous reward associ stimuli predomin measur visual domain recent behavior studi valu driven attent demonstr involuntari attent captur previous reward associ sound emul behavior find within visual domain suggest common mechan attent captur valu across sensori modal howev neural correl modulatori role learn valu process auditori inform examin conduct neuroimag studi human particip use previous establish behavior paradigm measur valu driven attent auditori target identif task replic behavior find voluntari priorit involuntari attent captur previous reward associ sound task relev select process high valu sound support reduc activ dorsal attent network visual system fef intrapariet sulcus right middl frontal gyrus implic cross modal process bias competit task irrelev contrast high valu sound evok elev activ posterior pariet cortex repres greater fidel auditori cortex find reveal two distinct mechan priorit reward relat auditori signal voluntari involuntari mode orient differ manifest bias competit | D010296;D012201 | T023;T029;T041;T030 |
34,673,957 | effect tmem ek variant haplotyp incid ovin lentivirus infect ewe product lifetim exposur ovin progress pneumonia virus oppv small rumin lentivirus widespread throughout us sheep flock infect oppv lifelong effect multi system signific implic anim well product protein isoform lysin posit k haplotyp encod ovin transmembran protein tmem gene associ reduc suscept infect two copi present ie diplotyp convers ancestr protein isoform glutam posit e haplotyp associ high suscept infect least one copi present benefici effect tmem k allel ewe product previous measur control challeng experi major object studi ewe tmem diplotyp n respect born rear oppv infect dam manag continu natur exposur oppv ewe test serolog status mo interv yr incid infect ewe diplotyp signific lower p wherea incid among diplotyp ewe increas steadili reach asymptot approxim mo age total number weight lamb wean per ewe expos yr ewe diplotyp far exceed p diplotyp averag lamb kg respect present studi confirm tmem diplotyp anim reduc incid oppv infect correspond improv product flock high frequenc tmem haplotyp select haplotyp appear cost effect approach mitig impact econom import diseas | D016180 | T047 |
34,673,956 | durabl sar cov specif cell respons month postinfect character longev qualiti cellular immun respons sever acut respiratori syndrom coronavirus sar cov enhanc understand coronavirus diseas covid immun influenc clinic outcom prior studi suggest sar cov specif cell present peripher blood month infect analysi function durabl divers cellular respons long natur infect rang age diseas phenotyp need identifi prevent therapeut intervent | D007156;D000091246 | T025;T042 |
34,673,955 | electrophysiolog correl social decis make eeg investig modifi ultimatum game cooper behavior social decis make shown sensit manipul context howev remain unclear aspect context dynam social interact observ nonverb behavior may modul cooper decis associ neural mechan studi particip respond offer propos split ultimatum game follow observ propos approach friend avoid nonfriend behavior display dynam whole bodi anim avatar follow nonsoci interact control condit expect behavior result show particip tend greater accept rate unfair offer follow observ nonverb social interact propos compar control suggest enhanc effect social interact cooper decis erp result show greater n n respons begin social interact condit compar control greater sustain late posit respons observ approach avoid propos behavior compar control event relat spectral perturb ersp result show differenti sensit within theta alpha beta band observ social interact offer associ subsequ decis behavior togeth result point impact propos nonverb behavior subsequ cooper decis behavior neural level erp ersp find suggest modul attent monitor process biolog motion observ nonverb social interact influenc particip respons offer find shed light electrophysiolog correl respons observ social interact predict subsequ social decis | D004569;D055724 | T040;T034;T042;T060 |
34,673,954 | combin supplement sodium humat glutamin reduc diarrhea incid wean calv intestin microbiota metabolit chang studi conduct investig effect combin supplement sodium humat hna glutamin gln growth perform diarrhea incid serum paramet intestin microbiom metabolit wean calv exp calv random assign four treatment nc negat control basal diet h g basal diet extra oral gavag g hna g gln daili h g basal diet extra oral gavag g hna g gln daili h g basal diet extra oral gavag g hna g gln daili hna gln togeth mix ml milk replac age water age oral administr calf bottl morn feed trial calv hna gln group higher p averag daili gain adg lower p diarrhea incid control group exp calv random assign two treatment fed basal diet basal diet supplement ml hna gln trial calv supplement hna gln higher p adg igg concentr glutathion peroxidas gsh px total antioxid capac aoc activ serum lower p diarrhea incid well serum diamin oxidas dao isom lactic acid lac tumor necrosi factor tnf malondialdehyd mda concentr compar control group result intestin microbiota indic supplement hna gln signific increas p abund intestin benefici microbiota moreov supplement hna gln alter metabolit enrich kyoto encyclopedia gene genom pathway wean calv conclus combin supplement hna gln could decreas diarrhea incid wean calv via alter intestin microbi ecolog metabol profil | D000069196;D005973 | T007;T116;T121;T123;T001 |
34,673,953 | ipipa cooper ocrl support endocyt traffic zebrafish pronephr tubul endocytosi fundament import process materi intern cell extracellular environ renal proxim tubul endocytosi abund scaveng receptor megalin co receptor cubilin play vital role retriev low molecular weight protein renal filtrat although know much megalin ligand machineri mechan receptor traffick endosom system remain poor defin studi show inositol phosphatas interact protein kda ipipa interact partner low syndrom protein oculocerebroren syndrom low ocrl requir endocyt traffic megalin within proxim renal tubul zebrafish larva knockout ipipa phenocopi endocyt phenotyp seen upon loss ocrl deficit uptak fluid phase protein cargo accompani reduct megalin abund alter endosom morpholog rescu co deplet experi indic ipipa function togeth ocrl support proxim tubul endocytosi result therefor identifi ipipa new player endocyt traffic proxim tubul vivo support view defect endocytosi under renal tubulopathi low syndrom dent diseas | D009800 | T047 |
34,673,945 | feed saccharomyc cerevisia ferment product lessen sever viral bacteri coinfect prewean calv previous report supplement saccharomyc cerevisia ferment product scfp amelior clinic sign lung patholog follow experiment bovin respiratori syncyti virus brsv infect prewean dairi calv object studi determin effect scfp supplement metabol endocrin respons diseas outcom viral bacteri coinfect prewean calv twenti seven old holstein angus cross calv enrol studi one scfp calf remov trial pre challeng phase due complic nephriti calv assign two treatment group control scfp treat base milk replac gd scfp smartcar solubl formula calf starter top dress gd scfp nutritek insolubl formula calv infect brsv day follow later intratrach inocul pasteurella multocida pm calv euthan day post viral infect calv receiv scfp reduc thorac ultrasonographi score day post viral infect p tendenc toward reduc score day post viral infect p calv receiv scfp also less sever lung patholog score necropsi p differ treatment observ lung viral load p bacteri lung recoveri p howev distinct lung locat pm recoveri pm isol frequent cranial lobe scfp treat calv frequent caudal lobe control calv calv treat scfp tend p higher serum il concentr follow coinfect calv treat scfp lower concentr serum nonesterifi fatti acid beta hydroxybutyr acid compar control follow experiment challeng p p respect suggest metabol chang favor growth develop differ group gene express insulin receptor insulin like growth factor igf igf receptor igf r growth hormon receptor haptoglobin liver result studi suggest supplement scfp may moder impact respiratori viral bacteri coinfect prewean calv metabol immun modif | D060085;D012441 | T004;T047 |
34,673,944 | cd box snorna snord af play dual role integrin signal arteri fibroblast function via pre mrna process ribos methyl previous shown cd box small nucleolar rnas snorna transcrib dlk dio locus human chromosom q associ cardiovascular diseas dlk dio snorna orphan snorna known target aim identifi rna target elucid mechan action human snord af mice af knockout cell non viabl induc overexpress inhibit af primari murin fibroblast perform rna seq identifi sever pre mrnas conserv afsnord seed bind site last exon untransl region utr direct pre mrna process splice variant specif protein express also pull snorna associ methyltransferas fibrillarin af high versus af low fibroblast lysat follow rna isol ribosom rna deplet rna seq identifi most mrnas subject panther pathway analysi observ enrich gene integrin pathway confirm ribos methyl six integrin pathway mrnas mapk itgb itga parvb ntn flnb methyl mrna express decreas mrna degrad increas afsnord inhibit murin human primari fibroblast effect protein express ambigu integrin signal crucial cell cell cell matrix interact correspond observ alter human primari arteri fibroblast function upon snord inhibit | D012322;D020537 | T114;T123 |
34,673,943 | genet variabl feed behavior crossbr grow cattl associ perform feed effici object present studi estim genet paramet sever feed behavior trait grow cattl well genet associ among feed behavior perform feed effici trait addit object investig use feed behavior trait predictor genet merit feed intak feed intak live weight data grow cattl use ultrasound data feed behavior data feed behavior trait defin base individu feed event meal event individu feed event group meal univari bivari anim linear mix model use estim co varianc compon herit estim se feed behavior trait rang meal per day feed time per day coeffici genet variat per trait vari meal per day durat feed event genet heavier cattl higher daili energi intak mei grew faster faster feed rate well greater energi intak per feed event per meal better daili feed effici ie lower residu energi intak genet associ shorter feed time per day shorter meal time per day valid popul steer heifer abil estim breed valu ebv mei predict adjust phenotyp mei demonstr ebv mei estim use multi trait model differ set predictor trait liveweight andor feed behavior correl se phenotyp mei ebv mei margin improv p feed behavior phenotyp valid popul includ genet evalu alreadi includ phenotyp mid test metabol live weight valid popul one largest studi demonstr signific exploit genet variat exist feed behavior young crossbr grow cattl feed behavior trait also genet correl sever perform feed effici metric nonetheless margin benefit inclus time relat feed behavior phenotyp genet evalu mei improv precis ebv trait | D000821;D005247 | T040;T168;T055 |
34,673,942 | phage display peptid display technolog phage display technolog base present peptid sequenc surfac bacteriophag virion develop year ago improv phage display system allow us employ method numer field biotechnolog divers immunolog biomed applic format novel materi mani other import phage display platform recogn award nobel prize phage display peptid antibodi contrast mani review articl concern specif applic phage display system publish recent year present overview technolog includ comparison various display system advantag disadvantag exampl applic various field scienc medicin broad sens biotechnolog peptid display technolog employ bacteri yeast mammalian cell well eukaryot virus cell free system also discuss power method still develop improv thus novel sophist tool base phage display peptid display system constant emerg new opportun solv various scientif medic technolog problem expect becom avail near futur | D001435;D019151 | T130;T116;T005 |
34,673,940 | necrotis fasciiti clinic judgement earli multidisciplinari collabor key necrotis fasciiti bacteri infect subcutan tissu fascia rapid progress septic shock diagnosi frequent delay miss due non specif present laboratori risk indic necrotis fasciiti lrinec stratifi risk base biochem result extern valid reveal limit accuraci year old femal signific co morbid present right foot pain erythema vital sign normal c reactiv protein mgl lnirec treat cellul within h develop skin blister necrosi consider risk washout debrid perform poplit block recoveri prolong complic nosocomi infect case highlight import clinic suspicion necrotis fasciiti complex manag decis consid recoveri protract | D019115 | T047 |
34,673,939 | transcutan auricular vagus nerv stimul strengthen semant represent foreign languag tone word initi stage learn difficulti perceiv phonolog contrast second languag l imped initi l lexic learn case english speaker learn tonal languag like mandarin chines given hypothes role reduc neuroplast adulthood limit l phonolog percept current studi examin whether transcutan auricular vagus nerv stimul tavn relat new neuromodulatori techniqu facilit l lexic learn english speaker learn mandarin chines day use doubl blind design one group particip receiv min continu prime tavn lexic train test day second group receiv msec peristimulus peristim tavn preced learn item task third group receiv passiv sham stimul result lexic recognit test administ end day reveal evid learn group higher likelihood accuraci across day peristim group greater improv respons time day prime group analys n erp compon elicit task indic behavior advantag tavn group coincid stronger lexico semant encod target word comparison find pupillometri result studi report panda n b phillip karuzi v p orourk p kuchinski e neurostimul pupillometri new direct learn research appli linguist annual review appli linguist suggest posit effect prime tavn peristim tavn lexico semant encod relat sustain attent effort | D007802;D055536 | T171;T061 |
34,673,938 | olfactori loss age connect health well age relat olfactori dysfunct presbyosmia common sensori impair age adult peopl demograph group comorbid condit exposur viral traumat environment insult remain greatest risk impair sever method assess olfact exist avail special set requir consider age sex ancestri cognit perhap import olfactori dysfunct suggest earli sign alzheim parkinson diseas therefor may serv tool diagnosi prognosi neurodegen condit outsid context olfactori loss also impact nutrit safeti social relationship even predict mortal review cover detect manifest olfactori declin age individu myriad way olfactori impair connect health well | D019636;D000857 | T033;T047 |
34,673,937 | genet mutat analysi patient congenit absenc vas deferen singl center studi congenit absenc vas deferen cavd congenit malform male reproduct system caus obstruct azoospermia male infertil current cystic fibrosi transmembran conduct regul cftr recogn main pathogen gene cavd gene adhes g protein coupl receptor g adgrg solut carrier famili isoform slca sodium channel epitheli subunit beta scnnb carbon anhydras ca candid gene pathogenesi cavd howev frequenc spectrum mutat well pathogen mechan cavd fulli investig sequenc gene potenti pathogen mutat use next generat sequenc verifi identifi variant sanger sequenc bioinformat analysi perform predict pathogen mutat describ distribut pvm poli tg repeat cftr polymorph identifi novel missens mutat cftr slca gene respect taken togeth identifi mutat cftr adgrg slca scnnb ca gene patient cavd thus broaden genet spectrum chines patient cavd | D009154 | T045 |
34,673,936 | protein intervent augment effect resist exercis appendicular lean mass handgrip strength older adult systemat review meta analysi random control trial increas protein intak suggest strategi slow revers loss muscl mass strength observ sarcopenia result studi direct test possibl inconsist | D055070;D055948 | T047;T061 |
34,673,935 | age still child complex strain gain older children care near centenarian mother longer live increas possibl care duti mean older adult look age parent well partner becom increas common scenario develop countri | D000087662;D009035 | T092;T100;T099 |
34,673,934 | novel nup jade fusion patient acut myeloid leukemia resembl acut promyelocyt leukemia acut promyelocyt leukemia apl specif subtyp acut myeloid leukemia aml character block differenti promyelocyt stage presenc pml rara fusion rare instanc rara fuse partner variant apl infrequ non rara gene rearrang aml patient resembl apl howev under diseas pathogenesi atyp case larg unknown report identif character nup jade fusion pediatr aml patient show apl like morpholog immunophenotyp mechanist show nup jade could impair tran retino acid atra mediat transcript control myeloid differenti intrigu nup jade found alter subcellular distribut wild type jade whose regul similar led attenu atra induc respons myeloid activ suggest nup jade may mediat jade inhibit knowledg first report nup non rar rearrang identifi aml patient mimick apl find suggest jade novel myeloid player involv retino acid induc differenti despit lack rearrang rara find implic alter retino acid signal jade disrupt may underli apl like featur case corrobor import signal apl pathogenesi | D015470;D015473 | T191 |
34,673,933 | transcriptom profil neonat mous granulosa cell reveal new insight primordi follicl activ dormant popul ovarian primordi follicl determin birth serv reservoir futur femal fertil yet understand molecular biochem cellular process underpin primordi follicl activ remain limit surviv primordi follicl reli correct complement morpholog granulosa cell provid signal factor essenti oocyt follicular surviv investig contribut granulosa cell primordi primari follicl transit gene express profil granulosa cell undergo earli differenti assess murin model ovari cbl mice enzymat dissoci time point span initi wave primordi follicl activ post natal day pnd ovari yield primordi granulosa cell pnd ovari yield mix popul primordi primari granulosa cell compar transcriptom granulosa cell time point generat via illumina nextseq system identifi signific differenti express transcript differenti express eight transcript confirm rt qpcr follow biolog network map via ingenu pathway analysi function express protein product three differenti express gene name frzb pod zfx investig situ immunoloc pnd mous ovari investig final evid provid wnt pathway antagonist secret frizzl relat protein frzb interact suppressor primordi follicl activ wnta may involv promot primordi follicl activ studi highlight dynam chang gene express granulosa cell primordi follicl activ provid evid renew focus wnt signal pathway role primordi follicl activ | D006080;D059467 | T086;T023;T081 |
34,673,931 | medic cost advanc ill last year life retrospect databas studi studi aim quantifi medic care utilis describ cost trajectori individu advanc ill last year life differenti advanc cancer end stage organ failur progress neurolog disord | D032722;D013727 | T058 |
34,673,930 | chromosom level genom assembl channa argusandchanna maculata compar analysi temperatur adapt channa argus channa maculata main cultur speci snakehead fish famili channida relationship close enough mate howev temperatur adapt quit differ | D002875;D005399 | T026;T013 |
34,673,929 | studi mutat rate evolut primat effect comput pipelin paramet choic commentari investig import role comput pipelin paramet choic perform mutat rate estim use recent articl publish journal bergeron et al entitl germlin mutat process rhesus macaqu implic phylogenet date illustr exampl | D018095;D059645 | T033;T045 |
34,673,928 | studi mutat rate evolut primat need systemat comparison comput pipelin lack consensus method estim germlin mutat rate pedigre led substanti differ comput pipelin publish literatur answer susann pfeifer opinion piec discuss pipelin choic recent articl estim germlin mutat rate rhesus macaqu macaca mulatta acknowledg differ method appli one prefer pfeifer yet advoc full transpar justif choic long rigor comparison pipelin remain absent way conclud best practic field | D018095;D059645 | T033;T045 |
34,673,927 | phytoestrogen lung cancer risk nest case control studi never smoke chines women sinc sever line evid suggest estrogen may involv lung carcinogenesi hypothes intak phytoestrogen similar molecular structur mammalian estrogen may associ lung cancer develop | D007529;D017705;D008175 | T191;T121;T109 |
34,673,926 | biomechan tendril adhes pad climb passion flower passiflora discophora climb passion flower passiflora discophora featur branch tendril multipl adhes pad tip allow attach larg diamet support flat surfac conduct tensil test quantifi perform attach system found forc failur vari substrat ontogenet state turgesc senesc tendril size ie tendril cross section area pad area tendril prove well balanc size attach firm varieti substrat forc failur n pull test perform tendril grown either epoxi plywood beech bark reveal senesc tendril could still bear forc measur turgesc tendril respect thus provid long last attach minim physiolog cost tendril main axi typic weakest part adhes system wherea pad substrat interfac never fail suggest plant use slight overs adhes pad strategi cope unpredict substrat pad togeth spring like main axi shown dissip larg amount energi straighten thus constitut fail safe attach system | D029598 | T002;T121;T168;T109 |
34,673,925 | home adapt intervent help reduc emerg fall admiss nation longitudin data linkag studi older adult live wale uk fall common older peopl evid effect prevent home adapt limit | D000058;D006760 | T058;T037 |
34,673,924 | larg divers linezolid resist isol discov food produc anim linezolid select monitor belgium linezolid critic import antibiot use treat human infect caus mrsa vre linezolid licens food produc anim linezolid resist lr isol report european countri includ belgium | D016984;D016908 | T007;T047 |
34,673,923 | understand experi live well beyond age year qualit analysi use theme meta ethnographi increas life expect necessarili match increas qualiti life | D019645;D011788 | T061;T078 |
34,673,922 | ash research collabor real world data infrastructur support real world evid develop learn healthcar system hematolog ash research collabor nonprofit organ establish american societi hematolog commit patient hematolog condit scienc inform clinic care futur therapi ash research collabor hous major initi data hub clinic trial network ctn data hub program hematolog diseas network clinic care deliveri site develop specif diseas area individu patient data contribut electron health record ehr integr direct data entri electron data captur extern data sourc diseas specif data model construct data assembl analyt dataset use enhanc clinic care dashboard mechan initi model built multipl myeloma mm sickl cell diseas scd use observ medic outcom partnership omop common data model cdm fast healthcar interoper resourc fhir standard data hub also provid framework develop diseas specif learn communiti lc test health care deliveri strategi ash research collabor scd ctn clinic trial acceler creat effici execut multicent clinic trial initi develop scd compon oper data hub activ aggreg sourc data scd ctn review studi candid manuscript describ process involv develop core featur ash research collabor inform stakehold communiti prepar expans addit diseas area | D006405;D000080891 | T091;T058 |
34,673,921 | gynecolog obstetr manag women von willebrand diseas summari systemat review literatur von willebrand diseas vwd disproportion affect women potenti heavi menstrual bleed hmb deliveri complic postpartum hemorrhag pph systemat synthes evid regard first line manag hmb treatment women requir desir neuraxi analgesia manag pph search medlin embas octob random trial compar observ studi case seri compar effect desmopressin hormon therapi tranexam acid txa hmb compar differ von willebrand factor vwf level women vwd undergo labor receiv neuraxi anesthesia measur effect txa pph conduct duplic studi select data abstract apprais risk bias whenev possibl conduct meta analys assess qualiti evid use grade grade recommend assess develop evalu approach includ random trial compar observ studi case seri moder certainti evid show desmopressin result smaller reduct menstrual blood loss differ mean chang baselin confid interv point pictori blood assess chart score compar txa low certainti evid first line treatment compar effect differ vwf level women receiv neuraxi anesthesia effect postpartum administr txa evid relev gynecolog obstetr manag women vwd address guidelin low qualiti futur studi address research prioriti key updat guidelin | D008595;D006473;D014148;D014842 | T047;T046;T121;T109 |
34,673,918 | effect function task exercis everyday problem solv abil function status older adult mild cognit impair randomis control trial investig effect function task exercis everyday problem solv abil function status older adult mild cognit impair compar singl exercis cognit train treatment control | D000203;D060825 | T080;T048;T056 |
34,673,917 | preval malnutrit risk among older french adult culinari depend term culinari depend denot situat someon deleg part daili meal relat activ third parti present studi aim explor nutrit risk among older peopl year culinari depend | D044342 | T047 |
34,673,916 | clinic activ safeti cabozantinib brain metastas patient renal cell carcinoma patient brain metastas renal cell carcinoma rcc underrepres clinic trial effect system therapi lack cabozantinib show robust clinic activ metastat rcc effect brain metastas remain unclear | D001932;D002292;D007680 | T191 |
34,673,915 | potenti inappropri medic effect fall hospit admiss investig effect potenti inappropri medic pim inpati fall identifi whether pim defin stoppfal design section k fall stopp v stronger associ inpati fall compar general tool stopp v | D000058;D000067561 | T080;T037 |
34,673,914 | associ deficit identifi geriatr assess deterior health relat qualiti life patient treat head neck cancer accumul geriatr deficit lead increas frailti state make patient suscept declin health relat qualiti life hrqol treatment head neck cancer hnc | D015577;D011788 | T058;T078 |
34,673,913 | patient caregiv experi particip parkinson diseas clinic trial systemat review qualit studi older peopl experi multipl barrier enrol clinic trial caregiv play import role support patient parkinson diseas understand experi patient caregiv particip trial import inform design futur studi identifi problem recruit retent | D017028;D010300 | T097;T047;T098;T099 |
34,673,912 | time updat immunohistochemistri molecular classif diagnosi risk assess endometri carcinoma endometri carcinoma common gynecolog malign unit state tradit classifi base histolog howev distinct certain histolog subtyp base morpholog uncommon problemat immunohistochem studi often need advanc comprehens tumor sequenc provid novel molecular profil endometri carcinoma four distinct molecular subtyp differ prognost valu propos cancer genom atlas program polymeras epsilon ultramut microsatellit instabl hypermut copi number low microsatellit stabl specif molecular profil copi number high serouslik p mutant | D014408;D007150;D025202 | T059;T063;T060;T123 |
34,673,906 | benefit stimulus size v perimetri patient dens central scotoma leber hereditari optic neuropathi leber hereditari optic neuropathi lhon common mtdna optic neuropathi frequent caus dens bilater central scotoma often character clinic studi humphrey visual field test hvf use stimulus size iii provid numer quantif visual field defect use mean deviat howev size iii test strategi limit use stimulus size v monitor patient evalu intertest variabl dynam rang determin test reliabl reproduc | D029242;D058609 | T047;T060 |
34,673,905 | depth investig conjunctiv swab tear fluid symptomat covid patient observ cohort studi putat presenc sar cov ocular specimen put healthcar worker risk thorough examin conjunctiv swab tear fluid larg cohort covid patient | D000086382;D012367 | T047;T114;T067 |
34,673,904 | risk patholog extranod extens advers featur transor robot surgeri patient hpv posit oropharynx cancer understand patient specif risk advers histopatholog find primari surgeri human papillomavirus hpv posit oropharynx squamous cell carcinoma opscc may help guid patient consult | D000079822;D037981;D065287 | T191;T061 |
34,673,903 | allogen transplant car therapi autolog transplant failur dlbcl noncompar cohort analysi allogen transplant allohct chimer antigen receptor modifi car cell therapi potenti cuarat option diffus larg b cell lymphoma dlbcl relaps autolog auto hct although center intern blood marrow transplant research cibmtr prognost model predict outcom allohct dlbcl autohct failur correspond model car treatment similar patient popul avail noncompar registri analysi report outcom patient dlbcl year undergo reduc intens allohct car therapi axicabtagen ciloleucel prior auto hct failur appli cibmtr prognost model car recipi total patient includ year relaps nonrelaps mortal overal surviv os progress free surviv car treatment autohct failur respect correspond rate allohct cohort respect year os allohct recipi classifi low intermedi highveri high risk group accord cibmtr prognost score respect p correspond rate low intermedi highveri high risk car patient respect p registri analysi show car allohct provid durabl remiss subset patient dlbcl relaps prior autohct simpl cibmtr prognost score use identifi patient high risk treatment failur either procedur evalu novel relaps mitig strategi cellular immunotherapi warrant high risk patient | D018380;D016403;D000076962 | T191;T116;T129;T192;T061 |
34,673,901 | retin vegf overexpress suffici induc lymphangiogenesi regardless vegf c upregul lyve macrophag infiltr lymphat vessel identifi retina studi investig whether patholog vegf overexpress diabet retina caus lymphangiogenesi | D005786 | T045 |
34,673,900 | perceptu learn crowd task effect anisotropi optotyp visual crowd refer impair recogn peripher present object flank distractor crowd effect exhibit certain spatial extent target flanker reduc perceptu learn experi investig learn induc reduct crowd normal sight particip test learn one optotyp landolt c transfer anoth tumbl e vice versa twenti three normal sight particip year train crowd task right upper quadrant target degre eccentr four session half particip four altern forc choic task discrimin orient landolt c half particip task discrimin orient tumbl e flank distractor fifth session particip switch untrain optotyp respect learn success measur reduct spatial extent crowd found overal signific compar learn induc reduct crowd condit landolt c tumbl e howev group train landolt c task learn effect transfer optotyp specif target flanker constel may modul transfer effect found perceptu learn crowd task optotyp could promis tool rehabilit program help improv peripher vision eg patient central vision loss depend possibl transfer effect optotyp distractor use requir clarif | D007858;D014796 | T061;T062;T041 |
34,673,899 | dynam nois background reveal perceptu motion extrapol twinkl goe illus find dynam nois background perceiv disappear locat move object shift direct motion twinkl goe illus requir lumin chromat base confus object background amount background motion energi direct object motion suggest illus enabl dynam nois mask offset transient otherwis accompani object disappear result consist anticipatori process pre activ posit ahead object current posit addit find suggest altern account continu attent track object disappear first shift increas speed revolut per second rps near attent track limit second shift great reduc attent divid two move object final illus associ delay simpl reaction time disappear object propos absenc offset transient attent track keep move sever ten millisecond target disappear caus one hallucin move object posit attent | D007088;D009039 | T033;T048;T041 |
34,673,898 | laps care among patient assign ranibizumab prolif diabet retinopathi post hoc analysi random clinic trial follow schedul individu eye treat anti vascular endotheli growth factor agent prolif diabet retinopathi pdr requir patient return frequent monitor repeat treatment likelihood patient compli consider choos treatment approach | D003920;D003930;D008269 | T047 |
34,673,897 | comprehens geriatr assess newli diagnos older myeloma patient multicentr prospect non intervent studi multipl myeloma diseas older peopl whose prognos high heterogen intern myeloma work group imwg propos geriatr assess ga base age function status comorbid discrimin fit frail patient given multidimension natur frailti relat recent explor frailti field mm reach consensus measur frailti mm patient remain challeng | D000073496;D009101 | T033;T191;T046;T184 |
34,673,895 | effect mg vs mg dexamethason number day aliv without life support adult covid sever hypoxemia covid steroid random trial daili dose mg dexamethason recommend day patient sever critic covid higher dose may benefit sever diseas | D008020 | T058;T080 |
34,673,890 | work group recommend practic teleneuropsycholog latin america teleneuropsycholog telenp could potenti expand access servic patient confin limit person access healthcar live remot area emerg covid pandem signific increas use telenp cognit assess main object recommend identifi procedur potenti best adapt practic telenp latin america therebi facilit profession decis make region | D000086382;D058873 | T047;T067 |
34,673,889 | implicit bias associ redact identifi resid applic screen score divers ophthalmolog profess import provid care increas divers patient popul howev implicit bias may inadvert disadvantag underrepres applic resid recruit select | D007396;D009885 | T097;T065;T091 |
34,673,888 | updat incid preval surviv initi treatment patient non small cell lung cancer us updat estim non small cell lung cancer nsclc us need | D002289;D008175 | T191 |
34,673,885 | cost effect evalu us prevent servic task forc recommend lung cancer screen us prevent servic task forc uspstf issu recommend lung cancer screen lower start age screen year minimum cumul smoke exposur pack year relat recommend although cost expect increas expand screen elig criteria unknown whether new guidelin lung cancer screen cost effect | D008175;D016540 | T191;T055 |
34,673,884 | dutch emerg physician insuffici educ geriatr emerg medicin result nationwid survey emerg physician ep provid care older adult complex health problem treat patient challeng mani ep might origin modest geriatr educ | D004635;D005853;D010820 | T091;T097;T090 |
34,673,880 | nurs care covid patient hemodialysi prone posit experi report describ experi report nurs provid care covid patient hemodialysi prone posit | D000086382;D009732 | T058;T047;T067 |
34,673,879 | special nurs terminolog prevent fall elder primari care build special nurs terminolog prevent fall elder primari healthcar base icnp | D000072917 | T170 |
34,673,878 | citizen involv scientif activ extens knowledg societi high qualiti health research must involv citizen bring merit relev valu research ensur transfer new knowledg output communiti theoret studi aim conceptu discuss role citizen involv extens societi research process outcom reveal concept differ purpos research unit research fund agenc promot citizen involv step research process add qualiti moreov univers research unit research extend knowledg societi citizen end user part social respons citizen involv extens societi consid strateg area develop research general nurs research particular studi need generat new knowledg use product better serv real need societi | D015399 | T062 |
34,673,872 | edtmp ligand enhanc water interact endow iron oxid nanoparticl dual modal mri contrast abil singl modal magnet reson imag mri contrast agent sometim caus signal confus clinic diagnosi util ligand endow iron oxid nanoparticl io nps excel dual modal mri contrast effici might effect strategi improv diagnost accuraci work present develop special ligand assist one pot approach prepar super hydrophil magnet nps excel water dispers biocompat dual modal contrast enhanc properti addit strong bind capac ethylenediamin tetramethylenephosphon acid edtmp ligand water molecul induc presenc abund hydrogen bond signific improv spin lattic spin spin imag io core modifi edtmp ligand relax rate io core dramat increas mm mm moder relax rate mm observ simultan impli nps averag size nm may potenti candid high effici mri contrast agent fundament techniqu use super hydrophil ligand endow io nps dual modal contrast properti without size chang damag contrast effect may provid use strategi facilit applic magnet nps field medic diagnosi | D008279 | T170;T059;T060 |
34,673,871 | lycopen prevent dehp induc testicular endoplasm reticulum stress via regul nuclear xenobiot receptor unfold protein respons mice lycopen lyc potent antioxid synthes red veget plant di ethylhexyl phthalat dehp frequent detect divers agricultur environ consid reproduct toxic present research design assess potenti mechan dehp induc testicular toxic treatment efficaci lyc studi oral administr lyc dose mg per kg bw per day mice given mg per kg bw per day dehp research suggest lyc prevent dehp induc disord level activ content cyp enzym lyc attenu dehp caus enhanc nuclear xenobiot receptor nxrs phase metabol enzym cyp cyp cyp etc level furthermor endoplasm reticulum er stress induc dehp trigger unfold protein respons upr interest lyc could effect amelior hit present studi suggest lyc prevent dehp induc er stress testi via regul nxrs upr er | D059865;D056811;D015262 | T049;T131;T043;T123 |
34,673,870 | host cell assist construct folat engin nanocarri base viral light particl target cancer therapi target cancer therapi arous broad interest research due accuraci specif tumor target side effect normal cell last decad oncolyt viral light particl l particl transform smart nanocarri target drug deliveri howev l particl similar oncolyt virus deriv recogn tumor cell express correspond receptor sever limit univers applic although modif target agent onto envelop overcom limit still great challeng without interf biofunct sinc envelop fragil herein host cell assist strategi propos construct folat engin nanocarri f l particl biofunct maintain largest extent f l particl multi function encapsul ultrasmal near infrar quantum dot antitumor drug tumor real time imag therapi moder effici conveni cell base strategi facilit develop widespread applic bio nanocarri field target cancer therapi drive interdisciplinari studi nanotechnolog chemistri virolog | D000970;D009369;D045663 | T191;T121;T073;T109 |
34,673,869 | impact soy lecithin zinc oxid methylsulfonylmethan excipi ingredi bioaccess intestin transport branch chain amino acid anim plant protein mixtur maxim biolog activ branch chain amino acid bcaa necessari find new excipi agent increas bioavail bcaa protein mixtur aim current studi investig effect soy lecithin slc zinc oxid zno methylsulfonylmethan msm bioaccess intestin transport bcaa anim plant protein mixtur pms via vitro digest model human intestin epitheli caco cell bioaccess total bcaa pms consider increas addit slc combin effect slc zno msm enhanc bioaccess total bcaa observ interest slc show major role bind bile acid show bind capac intestin transport bcaa measur g ml leucin isoleucin valin respect pms slc zno msm eventu amplifi amount total transport bcaa g ml time higher pm cellular integr digesta treat caco cell tend decreas accord incub time recov treatment pm slc zno msm near reach control level result current studi suggest co consumpt protein equal consist plant anim sourc slc zno msm could improv bioavail total bcaa result improv health benefit | D000597;D010940 | T116;T123 |
34,673,866 | switch aptam attach geometri dramat alter signal perform electrochem aptam base sensor electrochem aptam base eab sensor compos electrod bound dna aptam redox report distal end offer promis high frequenc real time molecular measur complex sampl matric even vivo assess extent switch aptam terminus electrod bound one redox report modifi affect perform sensor use sensor doxorubicin cocain vancomycin test bed find signal gain relat signal chang seen presenc satur target frequenc depend gain depend strong attach orient suggest easili investig variabl worthwhil paramet optim design new eab sensor | D015374;D055664 | T059;T075 |
34,673,864 | effect chiral anticanc activ pt ii pt iv complex contain r r enantiom tran diamino cyclohexen ligand dachex analogu diaminocyclohexan use oxaliplatin six enantiomer pure oxaliplatin like platinum compound two platinum ii four platinum iv contain unsatur cyclic diamin tran diamino cyclohexen dachex substitut tran diaminocyclohexan use oxaliplatin investig complex character element analys esi ms h nmr spectroscopi four pt iv complex electrochem redox behaviour investig cyclic voltammetri show complex possess reduct potenti suitabl activ vivo antiprolif activ assess vitro human cancer cell line also select resist platinum base drug belong multidrug resist mdr phenotyp complex exhibit antiprolif activ superior cisplatin almost equival better oxaliplatin moreov complex also capabl overcom cisplatin oxaliplatin resist compar effect enantiomer pure compound racem one r r enantiom emerg effect case pt ii complex wherea enantiom effect case pt iv deriv result obtain also spheroid tumor model cis tran cis pt oxa obz dachex obz benzoat emerg promis candid preclin investig | D000077150 | T121;T109 |
34,673,862 | virus templat magnet composit hydrogel surfac immobil mimic free lipas surfac immobil enzym magnet recover carrier great interest import biocatalysi relat larg molecul work nanos amino rich filament virus versatil biolog scaffold appli uniqu soft backbon lipas immobil base structur capsid protein phage magnet recover mimic free lipas mfls compos hydrogel magnet particl develop two design first design nanos wild phage crosslink phage hydrogel n termin pviii peptid nh fe magnet nanoparticl mnps attach virus glutaraldehyd form nh fe magnet phage hydrogel second design special fe affin piii peptid fap biopan strong bind toward bare fe hook like piii peptid n lplstqh c tem observ confirm direct grasp fap bare fe form magnet fap fe virus hydrogel lipas uniform anchor phage surfac nanoscal crosslink n termin pviii peptid lipas nh fe lipas fap fe mfls construct mfls high activ recoveri yield effici magnet separ character signific reduc mnp usag amount enhanc lipas load amount fold obtain compar convent nh fe carrier quantifi k v max k valu almost equal free lipas verifi free enzym mimick featur mfls high ph toler wide temperatur adapt enhanc thermal stabil stabl magnet separ capabl mfls also observ particular fap fe magnet virus hydrogel simpli use bare fe mnps would conveni econom scale biocatalysi | D008049;D058185 | T130;T116;T121;T126 |
34,673,860 | attomolar analyt sens techniqu attosen review decad progress chemic biosens nanoplatform detect ultra low abund analyt real life sampl biolog fluid water soil food requir design develop high perform biosens modal breakthrough effort scientif communiti led realize sens technolog measur analyt ultra trace level relev sensit select respons time sampl effici refer attomolar analyt sens techniqu attosen review attosen platform detect correspond quantif target analyt molecul l sampl volum herein review approach list various sensor probe design sens strategi pave way detect attomolar concentr analyt summari technolog advanc made divers attosen trend past decad present | D015374 | T059;T075 |
34,673,853 | tumor microenviron nanotherapeut intrud tumor fort recent year advanc nanomedicin allow new approach diagnos treat tumor nano drug deliveri system exploit enhanc permeabl retent epr effect enter tumor tissu interstiti space howev tumor barrier play crucial role caus ineffici epr home effect mount evid support hypothesi compon tumor microenviron extracellular matrix cellular physiolog compon collect cooper hinder entri distribut drug therefor limit theragnost applic cancer nanomedicin abnorm tumor microenviron play pivot role cancer nanomedicin recent recogn promis target improv nano drug deliveri therapeut outcom strategi like passiv activ target stimuli trigger nanocarri modul immun compon shown promis result achiev anticanc efficaci present review focus tumor microenviron nanoparticl base strategi polymer inorgan organ nanoparticl intrud tumor barrier improv therapeut effect | D000970;D053758;D009369 | T191;T121;T073;T109 |
34,673,852 | direct determin boscalid grape sampl differenti puls voltammetri use carbon past electrod new methodolog determin direct fungicid boscalid bsc develop success appli red grape juic peel extract pulp purpl grape seed viti labrusca l work carbon past electrod cpe without sampl prepar cyclic voltammetri cv indic presenc irrevers cathod process bsc v vs agagcl kcl mol l solut mol l hclaceton vv behavior also observ use squar wave voltammetri swv differenti puls voltammetri dpv techniqu prove sensit higher select bsc quantif influenc ph reduct bsc investig britton robinson buffer brb mol l ph limit detect lod valu obtain calibr curv differ sampl follow mg l deioniz water mg l red grape juic mg kg peel extract mg kg grape pulp mg kg grape seed correspond limit quantif loq valu sampl follow mg l mg l mg kg mg kg mg kg respect addit recoveri rate differ concentr level investig rang vari test perform sampl requir extract pre concentr step bsc result fast simpl cheap methodolog | D002244;D027843 | T116;T121;T002;T129;T168;T196 |
34,673,850 | cell membran anchor coval organ framework nanosheet singl laser trigger synergist tumor therapi herein phlip engin cof nss develop cell membran anchor synergist tumor therapi singl laser irradi | D010789 | T061 |
34,673,849 | green tea extract reduc eros dentin wear caus energi drink vitro investig effect energi drink supplement green tea extract eros dentin wear | D061215;D010936;D014077 | T047;T121;T168;T123 |
34,673,848 | treatment gingiv pregnanc improv pregnanc outcom systemat review meta analysi studi aim investig whether treatment gingiv pregnant women affect pregnanc outcom | D005891;D047928 | T047;T046 |
34,673,847 | oral hygien associ orthodont pain patient treat stabilis periodont prospect cohort studi aim determin whether oral hygien oh factor affect orthodont pain reveal whether orthodont pain affect oh practic orthodont treatment | D009910;D010518 | T047;T055 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.